oral glp 1 drugs in development GLP-1: how to win the next GLP-1 era Peptide GLP-1 receptor agonists: From
Description
New indications expand use cases Perhaps just as important as the wave of new GLP-1/GIP drugs for obesity is the expansion of already approved GLP-1 drugs into other therapeutic areas
Add more beans to your diet
Yet, therapeutic options remain mostly symptomatic and of limited efficacy for the metabolic and reproductive alterations of PCOS
Brnden A, Albr A, Rohde U, Gasbjerg LS, Rehfeld JF, Holst JJ, et al
GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity
